Estimates are 30-50% of available medications are of low quality or counterfeit in countries with failed governance and conflict. These fake medications are a serious clinical problem and becoming a public health concern. Thirty-six distinct technologies have been described to prevent fake medicines but none meet the needs for point of care testing in low resource or conflict environments.